Peter Moran

Peter Moran has extensive experience in the healthcare and technology sectors, serving as a seed investor and advisor across multiple innovative companies. Currently, Peter is a board member and seed investor at Iterative Scopes, focused on improving treatments for Irritable Bowel Disease and reducing colorectal cancer rates. Peter also invests in Midi Health, a connected device for nicotine addiction, and Proprio Vision, which enhances surgeon capabilities through advanced imaging technologies. Additional investments include sound health startups such as LeanTaaS, Peak Energy, Signos, Subtle Medical, and General Prognostics. Educationally, Peter holds multiple advanced degrees in Mechanical Engineering, Electrical Engineering, and Management from Stanford University and the Massachusetts Institute of Technology.